Day 1: Oct 10th
Jump to Day 2
Morning session 1: 9-10:30
9:00-9:15: Welcome: Why mammographic density?
9:15-9:30: What are the measurement issues?
9:30-9:50: What is BreastScreen’s perspective?
9:50-10:10: What is the Patient’s perspective?
10:10-10:20: What is the role of GPs?
Morning tea break 10:30-11am
Morning session 2: 11-12
11:00-11:20 What is happening in the US?
11:20-11:40 What are the Ethical and Legal Considerations?
11:40-12:00 What do BreastScreen participants know and do?
12:30-1:30: VCCC Breast Tumour Grand Rounds: Preventive therapy for breast cancer
Afternoon session 1: 1:30-3:30
1:30-1:50 What are the Health Economic implications of mammographic density in tailored screening?
1:50-2:10 What are the implications of Family History?
2:10-2:30 What is the underlying Biology?
2:30-3:00 Questions and Discussion
Afternoon tea break 3:00-3:30pm
Afternoon session 2: 3:30-5:00
3:30-3:50 What is the Radiologist’s perspective?
3.50-4.10 What is the Clinician’s perspective?
4:10-4:20 What is BCNA’s (Breast Cancer Network Australia) Perspective?
4:20-4:30 What is the VCCC’s (Victorian Comprehensive Cancer Centre) project on tailored screening?
4:30-4:40 Who are the other stakeholders?
Conference dinner – Parkville precinct 6:30pm for 7pm start
Day 2: Oct 11th
Jump to Day 1
Morning session 1: 9-10:30: The Measurement of Breast Density
9:00-9:20 (+5min Questions) Optical Breast Spectroscopy (OBS) to identify women with elevated Mammographic Density and monitor its change in real time
9:25-9:35 (+5min Questions) Novel methods for measuring breast density in younger women: TiBS and DXA
9:40-10:00 (+5min Questions) Effect of double-reading versus single-reading on the association between mammographic sensitivity and volumetric breast density
10:05-10:25 (+5min Questions) Breast density in 35,000 BreastScreen mammograms: an overview of risk assessment and cancer outcomes using the AutoDensity automated measurement tool.
Morning tea break 10:30-11am
Morning session 2: 11-12:00: The Biology of Breast Density
11:00-11:15 (+5min Questions) Modulation of Syndecan-1 in human breast tissue explants: Role of estrogen signalling involving heparanase.
11:20-11:35 (+5min Questions) Associations between epithelial nuclear density (END), lobular involution (LI) and mammographic density (MD) among women undergoing diagnostic image-guided breast biopsy
11:40-11:55 (+5min Questions) Correlation of microCT with single-sided NMR T1 values as a measure of mammographic density
12:30-1:30 Plenary Talk: Title to be confirmed
Afternoon session 1: 1:30-3:30: Mammographic Density and Breast Cancer Risk
1:30-1:50 (+5min Questions) Association between mammographic breast density and breast cancer risk following a benign breast biopsy
1:55-2:05 (+5min Questions) The distribution and determinants of mammographic density in Western Australian Aboriginal women and its association with breast cancer risk
2:10-2:30 (+5min Questions) Risk of Interval Breast Cancer by Breast Density, Family History, and Breast Tissue Ageing
2:35-2:55 (+5min Questions) Longitudinal modelling of mammographic density for accurate breast cancer risk estimation
Emma C. Atakpa
3:00-3:30 Afternoon tea
Afternoon session 2: 3:30-5:00: You don’t want to miss…
3:30-3:45 (+5min Questions) Genome-wide association analysis of mammographic density in Malaysian women
3:50-4:05 (+5min Questions) Genetic profiles of breast cancers that arise in women with high or low MD
4:10-4:25 (+5min Questions) Impact of rapid weight loss on mammographic density
4:30-4:45 (+5min Questions) How does breast density notification make women feel?
4:50-5:00pm Meeting close and final comments